Doctolib

Headquarters: France

Filing date: 2026-09-20

Estimated valuation: $7.0B

Executive Summary

Doctolib is Europe's leading healthcare booking and telehealth SaaS platform, serving over 400,000 practitioners across France, Germany, and Italy. The company holds a dominant market position due to its early entry and comprehensive service offerings. Continued growth will be driven by further penetration into existing markets and potential expansion into new European countries. Doctolib's strong growth trajectory and market leadership make it a compelling candidate for a potential IPO between 2025 and 2029.

Risk Analysis

Detailed risk factors, AI-graded risk score, financials, and analyst commentary for Doctolib are available to Pro subscribers.

Unlock the full report or browse 500+ pre-IPO prospects.